DEFA14A ·Filed Apr 21, 2026
Proxy solicitation materials
Actionable Insight • Neutral
This is a routine proxy filing with no immediate financial implications. Monitor for any subsequent filings that may contain material information.
BMRN drugs
BMRN drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60Entry
$54.16
T+0 close · Apr 21, 2026 · via day close
Latest settled
+10.77%
T+60 · $60.00
Vs SPY
+5.22%
α at T+60
Horizons
All settled
through T+60
- T+0 · Apr 22 $54.16entry
- T+1 · 7mo ago −0.72%α −0.33% · $53.77
- T+5 · 7mo ago −1.71%α −1.76% · $53.24
- T+20 · 6mo ago −8.04%α −11.20% · $49.81
- T+60 · 4mo ago +10.77%α +5.22% · $60.00
Price Chart
REPLAYWatch the reaction play outLoading chart...
How similar events traded
Executive Summary
BioMarin Pharmaceutical Inc. filed a definitive proxy statement (DEFA14A) for its annual shareholder meeting, which is routine corporate governance documentation.
Key Financial Metrics
Vote
director election
Key Facts
- Company filed a definitive proxy statement (DEFA14A) for its annual meeting
- This is a standard regulatory filing required for shareholder meetings
- No material financial information or significant corporate actions were disclosed in this filing
Financial Impact
None - this is a routine governance filing
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001628280-26-026298 |
| Document: 0001628280-26-026298-index-headers.html | 0001628280-26-026298 |
| Document: 0001628280-26-026298-index.html | 0001628280-26-026298 |
| Document: 0001628280-26-026298.txt | 0001628280-26-026298 |
Track record
16 reports on BMRN
2 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +8.91% at T+60 after the Apr 27, 2026 report. 3 of 5 went positive at some point.
Filters
- Nov 4, 202612d ago SC 13G/A Neutral 3/10 Entry $56.12 to $56.70 Now $57.99 +3.33% ▲ +1.03% −2.26% vs SPY
- Nov 2, 202614d ago 8-K Bearish 6/10 Entry $55.66 to $57.13 Now $57.99 −4.19% ▼ −2.64% −3.23% vs SPY
- Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $57.49 to $56.12 Now $57.99 +0.87% ▼ −2.38% +2.34% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $56.00 to $57.13 Now $57.99 +3.55% ▲ +2.02% +2.73% vs SPY
- Oct 6, 20265w ago 8-K Bearish 6/10 Entry $55.20 to $55.14 Now $57.99 −5.05% ▲ +0.11% −0.87% vs SPY
- Sep 15, 20268w ago 8-K Neutral 4/10 Entry $64.45 to $63.94 Now $57.99 −10.02% ▼ −0.79% −1.61% vs SPY
- Sep 14, 20269w ago 8-K Neutral 2/10 Entry $66.41 to $64.06 Now $57.99 −12.68% ▼ −3.54% −3.65% vs SPY
- Sep 1, 202610w ago 8-K Neutral 3/10 Entry $64.84 to $64.41 Now $57.99 −10.56% ▼ −0.66% −0.74% vs SPY
- Sep 1, 202610w ago Press Release Neutral 4/10 Entry $64.84 to $64.41 Now $57.99 −10.56% ▼ −0.66% −0.74% vs SPY
- Aug 31, 202611w ago 8-K Bullish 6/10 Entry $65.23 to $64.63 Now $57.99 −11.10% ▼ −0.92% −0.78% vs SPY
Showing 10 of 16
US Market Status
Market Closed · Opens Wed (9h 33m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers